HIV Risk Behavior in Opioid Dependent Adults Seeking Detoxification Treatment: An Exploratory Comparison of Heroin and Oxycodone Users

REFERENCES

• CDC. HIV/AIDS Surveillance Report, 2006. U. S. Department of Health and Human Services, Atlanta, Ga 2008
   Google Scholar
• SAMHSA. Heroin: Changes in how it is used, 1995–2005 The DASIS Report. Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD 2007
   Google Scholar
• SAMHSA. Nonmedical use of prescription pain relievers. Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD 2004
   Google Scholar
• SAMHSA. Results from the 2007 National Survey on Drug Use and Health: national findings. Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD 2008
   Google Scholar
• Sullivan L E, Moore B A, Chawarski M C, et al. Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. J Subst Abuse Treat 2008; 35: 87–92
   PubMed Web of Science ®Google Scholar
• Chitwood D D, Griffin D K, Comerford M, et al. Risk factors for HIV-1 seroconversion among injection drug users: a case-control study. Am J Public Health 1995; 85: 1538–1542
   PubMed Web of Science ®Google Scholar
• Miller M, Neaigus A. Sex partner support, drug use and sex risk among HIV-negative non-injecting heroin users. AIDS Care 2002; 14: 801–813
   PubMed Web of Science ®Google Scholar
• Sánchez J, Comerford M, Chitwood D D, Fernandez M I, Mccoy C B. High risk sexual behaviours among heroin sniffers who have no history of injection drug use: implications for HIV risk reduction. AIDS Care 2002; 14: 391–398
   PubMed Web of Science ®Google Scholar
• Riehman K S, Kral A H, Anderson R, Flynn N, Bluthenthal R N. Sexual relationships, secondary syringe exchange, and gender differences in HIV risk among drug injectors. J Urban Health 2004; 81: 249–259
   PubMed Web of Science ®Google Scholar
• Battjes R J, Pickens R W, Amsel Z. HIV infection and AIDS risk behaviors among intravenous drug users entering methadone treatment in selected U. S. cities. Journal of Acquired Immune Deficiency Syndrome 1991; 4: 1148–1154
   PubMed Web of Science ®Google Scholar
• Miller C L, Strathdee S A, Li K, Kerr T, Wood E. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs). Am J Drug Alcohol Abuse 2007; 33: 527–536
   PubMed Web of Science ®Google Scholar
• Des Jarlais D C, Arasteh K, Perlis T, et al. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS 2007; 21: 231–235
   PubMed Web of Science ®Google Scholar
• Mclellan A T, Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9: 199–213
   PubMed Web of Science ®Google Scholar
• Sobell L C, Sobell M B. Timeline followback user's guide: a calendar method for assessing alcohol and drug use. Addiction Research Foundation, TorontoCanada 1996
   Google Scholar
• Gossop M, Darke S, Griffiths P, et al. The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995; 90: 607–614
   PubMed Web of Science ®Google Scholar
• Joe G W, Simpson D D. HIV risks, gender, and cocaine use among opiate users. Drug Alcohol Depend 1995; 37: 23–28
   PubMed Web of Science ®Google Scholar
• Camacho L M, Bartholomew N G, Joe G W, Cloud M A, Simpson D D. Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance. Drug Alcohol Depend 1996; 41: 1–7
   PubMed Web of Science ®Google Scholar
• Baker A, Kochan N, Dixon J, Wodak A, Heather N. Drug use and HIV risk-taking behaviour among injecting drug users not currently in treatment in Sydney, Australia. Drug Alcohol Depend 1994; 34: 155–160
   PubMed Web of Science ®Google Scholar
• Brodbeck J, Matter M, Moggi F. Association between cannabis use and sexual risk behavior among young heterosexual adults. AIDS Behav 2006; 10: 599–605
   PubMed Web of Science ®Google Scholar
• Bellis M A, Hughes K, Calafat A, et al. Sexual uses of alcohol and drugs and the associated health risks: a cross sectional study of young people in nine European cities. BMC Public Health 2008; 8: 155–166
   PubMed Web of Science ®Google Scholar
• Woody G E, Donnell D, Seage G R, et al. Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET. Drug Alcohol Depend 1999; 53: 197–205
   PubMed Web of Science ®Google Scholar
• Sigmon S C. Characterizing the emerging population of prescription opioid abusers. Am J Addict 2006; 15: 208–212
   PubMed Web of Science ®Google Scholar
• Grau L E, Dasgupta N, Harvey A P, et al. Illicit use of opioids: is OxyContin a “gateway drug”?. Am J Addict 2007; 16: 166–173
   PubMed Web of Science ®Google Scholar
• Gordon C M, Forsyth A D, Stall R, Cheever L W. Prevention Interventions With People Living with HIV/AIDS: State of the Science and Future Directions. AIDS Education & Prevention 2005; 17: 6–20
   PubMed Web of Science ®Google Scholar
• Marsch L A, Bickel W K, Badger G J, Jacobs E A. Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing. Drug Alcohol Depend 2005; 77: 195–204
   PubMed Web of Science ®Google Scholar
• Lott D C, Strain E C, Brooner R K, Bigelow G E, Johnson R E. HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate buprenorphine, and methadone. J Subst Abuse Treat 2006; 31: 187–194
   PubMed Web of Science ®Google Scholar
• Semaan S, Des Jarlais D C, Sogolow E, et al. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr 2002; 30: S73–93
   PubMed Web of Science ®Google Scholar
• Prendergast M L, Urada D, Podus D. Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs. J Consult Clin Psychol 2001; 69: 389–405
   PubMed Web of Science ®Google Scholar
• Weinhardt L S, Forsyth A D, Carey M P, Jaworski B C, Durant L E. Reliability and validity of self-report measures of HIV-related sexual behavior: Progress since 1990 and recommendations for research and progress. Arch Sex Behav 1998; 27: 155–180
   PubMed Web of Science ®Google Scholar
• Johnson M E, Fisher D G. I., M., et al. Reliability and validity of not-in-treatment drug users' follow-up self-reports. AIDS Behav 2000; 4: 373–380
   Google Scholar